Sep 16, 2025
Leslie Galloway, EMIG Chairman, shared his analysis of VPAG. Here’s Charles’ key takeaways: · The NHS VPAG rebate is £1bn over 3 years and so is a fixed rebate with risk share. · Global Pharma CEOs have asked for lower rebates and a better deal, that...
Sep 16, 2025
Charles Joynson, WaveData MD, decided to have a look at the differences between the average market price for generics and the English drug tariff. He wanted to know if the gap between the two was being squeezed, resulting in some of the misery pharmacists are going...
Jul 23, 2025
Each month WaveData collects the prices of medicines and devices from pharmacies and dispensing doctors. These come from the price lists and invoices sent to these accounts by their suppliers. So what we’re looking at here is the ‘share of voice’ rather than market...
Jul 22, 2025
Each month WaveData collect the prices of brands and generics from pharmacies and dispensing doctors. These come from the price lists and invoices sent to these accounts by their suppliers. This means that what we’re looking at here is the ‘share of voice’ rather than...
Jul 15, 2025
Check out the latest UK Price Watch article in the Generics Bulletin for analysis and insight on May’s product launches, the biggest risers, the biggest fallers and the fastest movers…. with market data provided by WaveData. Dave Wallace editor at Generics Bulletin,...
May 27, 2025
Prior to the launch of generics in August 2011 the UK and Parallel Imported (PI) packs of Keppra Tabs 250mg 28 had very similar prices. However, post August 2011 the market changed completely. Firstly, generics appeared in the market and took six months to fall from...
